Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$269K Buy
5,489
+19
+0.3% +$884 0.02% 470
2025
Q4
$238K Sell
5,470
-41
-0.7% -$1.87K 0.02% 465
2025
Q3
$248K Buy
5,511
+146
+3% +$6.41K 0.02% 460
2025
Q2
$233K Sell
5,365
-132
-2% -$5.88K 0.02% 449
2025
Q1
$253K Buy
5,497
+20
+0.4% +$836 0.02% 410
2024
Q4
$206K Hold
5,477
0.02% 459
2024
Q3
$222K Buy
+5,477
New +$206K 0.02% 424
2024
Q2
Sell
-5,637
Closed -$212K 448
2024
Q1
$212K Buy
+5,637
New +$201K 0.02% 402
2023
Q3
Sell
-5,220
Closed -$213K 386
2023
Q2
$213K Sell
5,220
-550
-10% -$22.7K 0.03% 366
2023
Q1
$242K Sell
5,770
-100
-2% -$4.17K 0.03% 331
2022
Q4
$254K Buy
5,870
+61
+1% +$2.41K 0.04% 320
2022
Q3
$218K Sell
5,809
-858
-13% -$37.9K 0.03% 339
2022
Q2
$302K Hold
6,667
0.05% 298
2022
Q1
$318K Sell
6,667
-2,680
-29% -$114K 0.04% 312
2021
Q4
$385K Sell
9,347
-2,357
-20% -$88.8K 0.05% 283
2021
Q3
$404K Buy
11,704
+551
+5% +$18.8K 0.06% 260
2021
Q2
$352K Hold
11,153
0.05% 292
2021
Q1
$348K Sell
11,153
-732
-6% -$22K 0.06% 271
2020
Q4
$358K Sell
11,885
-1,177
-9% -$34.7K 0.07% 240
2020
Q3
$333K Buy
13,062
+1,190
+10% +$31.6K 0.07% 238
2020
Q2
$307K Buy
11,872
+397
+3% +$10.5K 0.07% 240
2020
Q1
$301K Sell
11,475
-2,101
-15% -$66.1K 0.08% 220
2019
Q4
$441K Sell
13,576
-196
-1% -$6.35K 0.09% 197
2019
Q3
$475K Buy
13,772
+125
+0.9% +$4.2K 0.11% 179
2019
Q2
$467K Sell
13,647
-3,104
-19% -$110K 0.11% 189
2019
Q1
$599K Buy
16,751
+2,835
+20% +$96.5K 0.14% 146
2018
Q4
$448K Sell
13,916
-1,896
-12% -$60.6K 0.12% 162
2018
Q3
$492K Sell
15,812
-63
-0.4% -$1.94K 0.11% 172
2018
Q2
$482K Sell
15,875
-1,099
-6% -$31.5K 0.12% 162
2018
Q1
$472K Sell
16,974
-744
-4% -$20.1K 0.13% 159
2017
Q4
$498K Buy
17,718
+4,466
+34% +$128K 0.13% 153
2017
Q3
$356K Buy
13,252
+2,176
+20% +$58.2K 0.1% 201
2017
Q2
$285K Buy
+11,076
New +$282K 0.1% 194

Other funds holding EXC

Smith, Moore & Co's EXC Position: Q1 2026 in Review

Smith, Moore & Co increased its Exelon (EXC) stake by 0.35% in Q1 2026, buying an estimated $884 and bringing the position to 5,489 shares worth $269K. The position accounts for 0.02% of the portfolio, ranked #470.

Smith, Moore & Co first reported a position in EXC in Q2 2017 and has held it in 33 quarters since. The position peaked at $599K in Q1 2019. 1,277 funds tracked by Wall St. Rank hold EXC as of Q1 2026.

  • Smith, Moore & Co held 5,489 shares of Exelon worth $269K as of Q1 2026.
  • Smith, Moore & Co bought 19 Exelon shares in Q1 2026, an estimated $884.
  • Exelon made up 0.02% of Smith, Moore & Co's portfolio in Q1 2026, its #470 holding.
  • Smith, Moore & Co first reported a position in Exelon in Q2 2017 and has held it in 33 quarters since.
  • Smith, Moore & Co's Exelon position peaked at $599K in Q1 2019.
  • 1,277 funds tracked by Wall St. Rank held Exelon as of Q1 2026.

Based on Smith, Moore & Co's 13F filing for Q1 2026, filed 5 May 2026.